Accessibility Menu
Adheris Health logo

Adheris Health(ASX) MDR

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-96%
5 Year-95%
1 Year-72%
1 Month-24%
N/A
Adheris Health last closing stock price
MetricPriceDate
Last closeAUD 0.012026-09-07
Adheris Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.14%AUD 0.012026-08-31
1 month-23.53%AUD 0.022026-08-07
3 month-31.58%AUD 0.022026-06-09
Year to date-35%AUD 0.022025-12-31
1 year-71.74%AUD 0.052025-09-05
3 year-94.35%AUD 0.232023-09-08
5 year-95.44%AUD 0.292021-09-08
Since inception-96.38%AUD 0.362015-12-01

Adheris Health Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$185.10M

Net Income (TTM)

-A$62.53M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Feb 26, 2026

MDR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Adheris Health

Adheris Health Limited is a healthcare information services company that specializes in pharmacy-driven patient engagement solutions. Operating in Australia, the United States, and the United Kingdom, the company aims to enhance medication management through its innovative platform, THRiV. Formerly known as MedAdvisor Limited, the company rebranded in November 2025.

Products and Services
  • THRiV: An omni-channel platform for patient and pharmacist engagement
  • Pharmacy-driven solutions to improve medication adherence
  • Comprehensive patient engagement strategies for healthcare providers
Growth Outlook
  • Recent quarterly revenue reached AUD 23.35 million, indicating strong market demand
  • Net income for Q2 2025 was AUD 7.35 million, showcasing profitability potential
  • Expansion into new markets is anticipated to drive future revenue growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 75.55 million reflects significant growth
  • Current ratio of 1.24 indicates solid short-term financial health
  • Net income margin of 31.48% in Q2 2025 demonstrates effective cost management
Adheris Health Limited is positioned to capitalize on the growing demand for healthcare technology solutions. The company's focus on pharmacy-driven patient engagement is critical in improving medication adherence, which is a significant challenge in healthcare today. With a robust platform like THRiV, Adheris Health is well-equipped to enhance patient outcomes and streamline pharmacy operations. The recent financial performance indicates a positive trajectory, with increasing revenue and a strong net income margin, suggesting that the company is on a path to sustainable growth. As the healthcare landscape continues to evolve, Adheris Health's innovative solutions may play a pivotal role in shaping the future of patient engagement and medication management.
AI Generated • Aug 18, 2026

Industry

Health Care Technology

Sector

Health Care

CEO

John Ciccio

Website

www.medadvisor.com.au

Headquarters

Camberwell, VIC 3124, AU

MDR Financials

Key Financial Metrics (TTM)

Gross Margin

-10.27%

Operating Margin

-49.15%

Net Income Margin

-58.80%

Return on Equity

-614.15%

Return on Capital

-42.67%

Return on Assets

-120.37%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

A$27.36M

Operating Income

-A$1.79M

EBITDA

-A$53.03M

Operating Cash Flow

-A$9.18M

Capital Expenditure

-A$856.72K

Free Cash Flow

-A$10.03M

Cash & ST Invst.

A$10.30M

Total Debt

A$17.40M

Adheris Health Performance Analysis

Adheris Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 97,963,27244.6%
20242024-06-30AUD 98,403,4040.4%
20252025-06-30AUD 62,994,989-36.0%
20262026-06-30AUD 33,958,311-46.1%
Adheris Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-12-31123.0%
Q42024-06-30-38.4%
Q22024-12-3122.7%
Q42025-06-30-89.7%
Adheris Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.02-54.7%
20242024-06-30AUD 0.00N/A
20252025-06-30AUD -0.11N/A
20262026-06-30AUD -0.03-70.4%
Adheris Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-12-31138.7%
Q42024-06-30-188.7%
Q22024-12-31122.5%
Q42025-06-30-4382.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

A$5.89M

-82.6%

Gross Profit

-A$11.32M

-332.0%

Gross Margin

-1.92%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-A$64.72M

-307.0%

EBITDA

-A$62.07M

-434.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

A$10.30M

-27.4%

Total Debt

A$17.40M

+32.9%

Accounts Receivable

A$7.82M

-33.3%

Inventory

A$0.00

N/A

Long Term Debt

A$17.31M

+40.6%

Short Term Debt

A$81.71K

-89.5%

Return on Assets

-1.20%

N/A

Return on Invested Capital

6.96%

N/A

Free Cash Flow

-A$8.13M

+52.8%

Operating Cash Flow

-A$8.24M

+52.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IME.AXImExHS Limited
A$0.32+0.00%
PAB.AXPatrys Limited
A$0.03+3.33%
NC6.AXNanollose Limited
A$0.08+0.00%
AGH.AXAlthea Group Holdings Limited
A$0.02-4.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About MDR

What is the current price of Adheris Health?

Adheris Health is trading at N/A per share.

What is the 52-week range for Adheris Health?

Over the past 52 weeks, Adheris Health has traded between N/A and N/A.

How much debt does Adheris Health have?

As of the most recent reporting period, Adheris Health reported total debt of A$131.74K.

How much cash does Adheris Health have on hand?

Adheris Health reported A$9.53M in cash and cash equivalents in its most recent financial results.

What is Adheris Health’s dividend yield?

Adheris Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services